World's Best Scientists 2026 revealed!
Digestive and Liver Disease
H-index 36

Digestive and Liver Disease

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 487 388 1302 35

Additional Metrics

Number of Best Scientists*: 581
Documents by Best Scientists*: 1505
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 113
SCIMAGO SJR: 1.091
Impact Factor: 3.8

Overview

Top Research Topics at Digestive and Liver Disease?

Digestive and Liver Disease investigates studies in Internal medicine, Gastroenterology, Surgery, Radiology and In patient. It explores research in Internal medicine and the adjacent study of Oncology. The journal dives deep in exploring the relationship between the study of Oncology and Hepatocellular carcinoma.

Gastroenterology research featured in Digestive and Liver Disease incorporates concerns from various other topics such as Pathology, Reflux, Liver transplantation and Ulcerative colitis.

  • Internal medicine (47.52%)
  • Gastroenterology (32.87%)
  • Surgery (12.50%)

What are the most cited papers published in the journal?

  • Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease (434 citations)
  • The changing pattern of epidemiology in hepatocellular carcinoma. (407 citations)
  • Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. (406 citations)

Research areas of the most cited articles at Digestive and Liver Disease:

The journal publications primarily focus on research topics in Internal medicine, Gastroenterology, Surgery, Immunology and Disease. Aside from discussions in Internal medicine, the published articles also deal with the subject of Endocrinology which intersects with Fatty liver disciplines. The journal articles tackle studies in Odds ratio and the interrelated subject of Confidence interval to gain insights into Gastroenterology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Cancer

The previous edition focused in particular on these issues:

The concepts of Internal medicine, Gastroenterology, In patient, Coronavirus disease 2019 (COVID-19) and Surgery are tackled in the journal. The journal features Internal medicine research that overlaps with concepts in Oncology. Digestive and Liver Disease connects the study in Gastroenterology with the closely related area of Fibrosis.

Digestive and Liver Disease encompasses presentations on Coronavirus disease 2019 (COVID-19), specifically Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Pandemic. Concepts in Ulcerative colitis, as well as related topics in Crohn's disease, are covered in the Inflammatory bowel disease research presented in Digestive and Liver Disease. The Disease study tackling the subject of Fatty liver is the focus of Digestive and Liver Disease.

The most cited articles from the last journal are:

  • COVID 19 and liver: An A-Z literature review. (24 citations)
  • Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis. (19 citations)
  • Systemic inflammation as fuel for acute liver injury in COVID-19. (16 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Digestive and Liver Disease (based on the number of publications) are:

  • Alessandro Gasbarrini (349 papers) published 13 papers at the last edition, 9 more than at the previous edition,
  • Guido Costamagna (310 papers) published 4 papers at the last edition, 20 less than at the previous edition,
  • Edoardo Savarino (233 papers) published 11 papers at the last edition, 20 less than at the previous edition,
  • A. Repici (230 papers) published 23 papers at the last edition, 12 less than at the previous edition,
  • G. Gasbarrini (221 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Digestive and Liver Disease (based on the number of publications) are:

  • Sapienza University of Rome (490 papers) published 20 papers at the last edition, 1 more than at the previous edition,
  • University of Bologna (455 papers) published 23 papers at the last edition, 8 more than at the previous edition,
  • University of Padua (429 papers) published 23 papers at the last edition, 4 more than at the previous edition,
  • University of Milan (377 papers) published 25 papers at the last edition, 8 more than at the previous edition,
  • University of Naples Federico II (277 papers) published 10 papers at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 54.70% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.57% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.95% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.06% of all publications and 51.42% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Clinical Empathy in Digestive and Liver Disease

An aspect worth considering regarding medical care in Digestive and Liver Disease concerns the application of clinical empathy. Besides focusing on research papers and professional achievements, the humanistic perspective in healthcare plays a significant role in patient care. Understanding patient perspectives, maintaining healthy communication lines, and empathizing with disease experiences enrich the healthcare experience - for both patients and healthcare professionals. Clinical empathy goes beyond scientific knowledge. It embodies a three-dimensional approach that combines cognitive, emotive, and articulative elements. The cognitive aspect enables the health professional to understand the patient's predicament. The emotive element facilitates a shared feeling with the patient, while the articulative aspect comprises conveying the understanding and shared feelings to the patient. Not only does clinical empathy boost patient satisfaction, but it also impacts health outcomes positively. For instance, increased empathy levels exhibited by healthcare providers can result in improved medication adherence, reduced pain levels, and more efficient management of chronic conditions. Moreover, empathy can have an empowering effect on patients, motivating them to actively participate in their medical treatments. For those aspiring to join the nursing profession, understanding and honing clinical empathy proves essential. One of the first stepping stones towards this journey involves getting the adequate educational training, such as fulfilling the \maine nursing license requirements nursing license education requirements\. By starting with the right academic guidance and developing empathy as an intrinsic skill, healthcare professionals can effectively contribute to the enriching medical environment encompassing the field of Digestive and Liver Disease.

Top Publications

  • Understanding short bowel syndrome: Current status and future perspectives.

    Sara Massironi;Federica Cavalcoli;Emanuele Rausa;Pietro Invernizzi

    (2020)
    111 Citations
  • Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.

    Douglas K. Rex;Raj Bhandari;Daniel G. Lorch;Michael Meyers

    (2021)
    108 Citations
  • Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

    Louis de Mestier;Come Lepage;Eric Baudin;Romain Coriat

    (2020)
    107 Citations
  • Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration

    Macarena Ortiz;Sandra A. Soto-Alarcón;Paula Orellana;Alejandra Espinosa

    (2020)
    95 Citations
  • COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine.

    Monica Siniscalchi;Fabiana Zingone;Edoardo Vincenzo Savarino;Anna D'Odorico

    (2020)
    80 Citations
  • Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis

    Vincenzo Cardinale;Gabriele Capurso;Gianluca Ianiro;Antonio Gasbarrini

    (2020)
    78 Citations
  • Systemic inflammation as fuel for acute liver injury in COVID-19.

    Maria Effenberger;Christoph Grander;Felix Grabherr;Andrea Griesmacher

    (2021)
    77 Citations
  • COVID-19 and intestinal inflammation: Role of fecal calprotectin

    (2020)
    77 Citations
  • Management of Helicobacter pylori infection: Guidelines of the Italian society of gastroenterology (SIGE) and the Italian society of digestive endoscopy (SIED).

    (2022)
    69 Citations
  • The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease.

    Angela Ancona;Claudia Petito;Irene Iavarone;Valentina Petito

    (2021)
    59 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional medicine, several online degree options can help broaden career prospects. Nurses looking to advance clinically without onsite requirements can explore the best online DNP programs, which emphasize leadership and advanced practice while minimizing clinical hour commitments.

Healthcare professionals aspiring to influence policy, administration, or organizational leadership may find great value in pursuing an online PhD in healthcare management. This pathway provides critical skills for managing complex healthcare systems and improving patient outcomes through effective management.

Pharmacy graduates aiming for advanced clinical roles or research opportunities can consider enrolling in online Pharm D programs. These programs often offer flexibility and technological integration to support working professionals.

For those passionate about physical health and rehabilitation, obtaining an online exercise physiology degree opens doors to careers in fitness, therapy, and wellness. This degree complements traditional medical education by emphasizing preventive care and physical performance.

Best Scientists Contributing to This Journal

Recently Published Articles